Paul Connolly, VP of Marketing at Ideagoras Conference, discusses C8 MediSensors' non-invasive glucose monitoring device and mobile app. The device uses light to detect glucose levels through the skin and transmits readings to a smartphone app. The app continuously measures glucose every 6 minutes, allows setting alerts, and sharing data with doctors. It aims to make diabetes management more convenient through a mobile solution. C8 MediSensors is taking a community-based approach, engaging influencers and bloggers to generate interest in their investigational product.

1. From Inspiration to Reality
The Power of Light
Paul Connolly, VP of Marketing
Ideagoras Conference | 22 November 2012

2. 0
40
80
120
160
200
WesternPacific SoutheastAsia Europe NorthAmericaand
Caribbean
MiddleEastand
NorthAfrica
SouthandCentral
America
Africa
2010 2030
Source: IDF Diabetes Atlas
Projected Number of People with Diabetes (MM)
2
Worldwide:
2010: 337 million
2030: ~500 million
Western
Pacific
Southeast
Asia
Europe North
America and
Caribbean
Middle East
and North
Africa
South and
Central
America
Africa
2010 2030
160
120
80
40
0
Epidemic of Diabetes: 350 Million People

3. 1,000,000,000
mHealth: A Natural Evolution in Healthcare
Q3/12
Source: Yahoo Finance
2,000,000,000
Smartphones in Use Globally
2015

4. mHealth for the Entire Community
 Patients: Convenience
 Healthcare Professionals: Compliance
 Insurers: Lower long-term costs

5. Case Study
The Power of Light

6. How It Works
1. Small light sensitive sensor,
worn against the abdomen
2. Light detects glucose molecules
3. Glucose reading transmitted
wirelessly to smartphone

7. Investigational device. Not approved for sale anywhere.
The C8M App
 Continuously measures
every 6 minutes
 Set High/Low Limits
with audible or vibrating
notifications
 Swipe to see historical data
 Share glucose logbook with
doctor via email export
 App updates & features
pushed via Google Play

8. A Day in the Life

9. A Community-Based Approach
Investigational device. Not approved for sale anywhere.
Co-Creating
Brand Equity
Engaged in Market
Conversations
Robust
Community

10. A New Voice in the Conversation
Investigational device. Not approved for sale anywhere.

11. Ripples of Community-Based Approach
Investigational device. Not approved for sale anywhere.
General
Press / Online
Diabetes
Press / Online
Diabetes
Advocacy Groups
Diabetes
Bloggers & KOLs

12. Finding the Online Influencers
The C8 MediSensors Diabetes Social Graph
12
C8 MediSensors
Confidential

13. Community Response
Investigational device. Not approved for sale anywhere.

14. Reservations
Investigational device. Not approved for sale anywhere.
0
50
100
150
200
250
300
350
400
450
500
March April May June July August September October
Cumulative YTD Reservations
Update with
latest stats.

15. www.C8MediSensors.com

16. Appendix

17. Talking points to consider
 Android OS – why? Marketshare?
 Eliminating an extra device
 Providing a free App via Google
Play
 Mobile App Features
 Company originally planned to
provide handset with system
 Ease of reach to Social
 Challenge filing medical mobile
app with notified body?
 Reach an already tech savvy T1D
audience
 Give users the flexibility of a
device (most are) already familiar
with
 People want something as easy
as an App that works with proven
modern technology
 Leverage mobile platform to ease
disease management (data
storage, comm w/ Doc)
 Flexibility to push App updates
 Considering an open platform for
3rd party App development /
partnerships
 Establishing trust / credibility with
this community